New faculty join CCR each year to contribute to our work of making breakthrough scientific discoveries to find cures and treatments for cancer.
H. Efsun Arda, Ph.D., has joined the Laboratory of Receptor Biology and Gene Expression as a Stadtman Tenure Track Investigator. Her research focuses on understanding the genomic information that governs development, differentiation and function of pancreatic cell lineages.
Steven Cappell, Ph.D., has joined the Laboratory of Cancer Biology and Genetics as a Tenure Track Investigator. Dr. Cappell’s laboratory research focuses on understanding how signal transduction networks are wired to form logical circuits to understand how these networks function in space and time to regulate diverse aspects of human physiology.
Freddy Escorcia, M.D., Ph.D., has been appointed as an Assistant Clinical Investigator in the Molecular Imaging Program. Dr. Escorcia’s work focuses on tumor-targeted, personalized cancer treatment. Dr. Escorcia is also a clinically trained radiation oncologist and treats patients with all tumor types amenable to radiation therapy.
Anupama Khare, Ph.D., has joined the Laboratory of Molecular Biology as a Stadtman Tenure Track Investigator. Dr. Khare’s research focuses on understanding how different microbial species co-exist in the same environmental niche and the molecular interactions in such communities.
Natalie Porat-Shliom, Ph.D., has joined the Thoracic and Gastrointestinal Oncology Branch as a Stadtman Tenure Track Investigator. Dr. Porat-Shli¬om’s research focuses on utilizing intravital microscopy for imaging and understanding the biology of human cancer.
Vassiliki Saloura, M.D., has been appointed as an Assistant Clinical Investigator in the Thoracic and Gastrointestinal Oncology Branch. Dr. Saloura’s laboratory investigates the role of histone and non-histone protein methylation in tumor growth, therapy resistance and immunogenicity in squamous cell carcinoma of the aerodigestive tract.
Anish Thomas, M.B.B.S., M.D., has been appointed as an NIH Lasker Scholar Tenure Track Investigator in the Developmental Therapeutics Branch. The goal of Dr. Thomas’ research is to systematically develop more effective therapies for patients with small cell lung cancer and similar chemotherapy-refractory tumors.
Sandra Wolin, M.D., Ph.D., has joined CCR as a Senior Investigator and as the inaugural Chief of the newly established RNA Biology Laboratory on the Frederick campus. She will continue the world-class research program she established at Yale University and will play a leading role in developing an integrated program in RNA biology in CCR.
Chuan Wu, M.D., Ph.D., has joined the Experimental Immunology Branch as a Stadtman Tenure Track Investigator. Dr. Wu’s research focuses on differenti¬ation of autoreactive T cells and the mechanism of neuro-immune crosstalk in autoimmunity.
Zhengping Zhuang, M.D., Ph.D., has joined the Neuro-Oncology Branch as a Senior Investigator. Dr. Zhuang’s research focuses on functional genomics and molecular signaling in central nervous system tumors to identify the critical genes and molecules in cancer formation and progression.